Advanced search
Publication Cover
Bioanalysis Volume 2, 2010 - Issue 3
Submit an article Journal homepage
376
Views
3
CrossRef citations to date
0
Altmetric
Review

Ocular Microdialysis: A Continuous Sampling Technique to Study Pharmacokinetics and Pharmacodynamics in The Eye

Sai HS BodduDivision of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO64108-62718, USA. [email protected]
,
Sriram GundaDivision of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO64108-62718, USA. [email protected]
,
Ravinder EarlaDivision of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO64108-62718, USA. [email protected]
&
Ashim K MitraDivision of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO64108-62718, USA. [email protected]Correspondence[email protected]
Pages 487-507 | Published online: 16 Mar 2010

Bibliography

  • Lee VH , RobinsonJR. Topical ocular drug delivery: recent developments and future challenges. J. Ocul. Pharmacol. 2(1), 67–108 (1986).
  • Schoenwald RD . Ocular Pharmacokinetics/pharmacodynamics. Mitra AK (Ed.). Dekker, NY, USA,307–330 (1993).
  • Hughes PM , OlejnikO, Chang-LinJE, WilsonCG. Topical and systemic drug delivery to the posterior segments. Adv. Drug Deliv. Rev. 57(14), 2010–2032 (2005).
  • Kaur IP , KanwarM. Ocular preparations: the formulation approach. Drug Dev. Ind. Pharm. 28(5), 473–493 (2002).
  • Dias CS , MitraAK. Posterior segment ocular pharmacokinetics using microdialysis in a conscious rabbit model. Invest. Ophthalmol. Vis. Sci. 44(1), 300–305 (2003).
  • Chefer VI , ThompsonAC, ZapataA, ShippenbergTS. Overview of brain microdialysis. Curr. Protoc. Neurosci. 7, 71 (2009).
  • Shippenberg TS , ThompsonAC. Overview of microdialysis. Curr. Protoc. Neurosci. 7(7), 1 (2001).
  • Plock N , KloftC. Microdialysis – theoretical background and recent implementation in applied life-sciences. Eur. J. Pharm. Sci. 25(1), 1–24, (2005).
  • Ungerstedt U , PycockC. Functional correlates of dopamine neurotransmission. Bull. Schweiz. Akad. Med. Wiss. 30(1–3), 44–55 (1974).
  • Rittenhouse KD , PollackGM. Microdialysis and drug delivery to the eye. Adv. Drug Deliv. Rev. 45(2–3), 229–241 (2000).
  • Waga J , EhingerB. Intravitreal concentrations of some drugs administered with microdialysis. Acta Ophthalmol. Scand. 75(1), 36–40 (1997).
  • Gunnarson G , JakobssonAK, HambergerA, SjostrandJ. Free amino acids in the pre-retinal vitreous space. Effect of high potassium and nipecotic acid. Exp. Eye Res. 44(2), 235–244 (1987).
  • Ben-Nun J , CooperRL, CringleSJ, ConstableIJ. Ocular dialysis. A new technique for in vivo intraocular pharmacokinetic measurements. Arch. Ophthalmol. 106(2), 254–259 (1988).
  • Mitra AK . In:Ophthalmic Drug Delivery Systems. Mitra AK (Ed.). Dekker, NY, USA (1993).
  • Verbeeck RK . Blood microdialysis in pharmacokinetic and drug metabolism studies. Adv. Drug Deliv. Rev. 45(2–3), 217–228 (2000).
  • de Lange EC , de Boer AG, Breimer DD. Methodological issues in microdialysis sampling for pharmacokinetic studies. Adv. Drug Deliv. Rev. 45(2–3), 125–148 (2000).
  • Maurice G . Handbook of Experimental Pharmacology. Born VR (Ed.). Springer-Verlag, Berlin, NY,20–116 (1984).
  • Duvvuri S , RittenhouseKD, MitraAK. Microdialysis assessment of drug delivery systems for vitreoretinal targets. Adv. Drug Deliv. Rev. 57(14), 2080–2091 (2005).
  • Macha S . In:Ophthalmic Drug Delivery Systems. Mitra AK (Ed.). Dekker, NY, USA 251–279 (2003).
  • Rittenhouse KD . Ophthalmic Drug Delivery Systems. Dekker, NY, USA, Mitra AK (Ed.).223–250 (2003).
  • Urtti A . Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv. Drug Deliv. Rev. 58(11), 1131–1135 (2006).
  • Katragadda S , GundaS, HariharanS, MitraAK. Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections. Int. J. Pharm. 359(1–2), 15–24 (2008).
  • Raviola G . The structural basis of the blood-ocular barriers. Exp. Eye Res. 25(Suppl.), 27–63 (1977).
  • Sheiner LB , RosenbergB, MaratheVV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J. Pharmacokinet. Biopharm. 5(5), 445–479 (1977).
  • Drusano GL , LiuW, PerkinsRet al. Determination of robust ocular pharmacokinetic parameters in serum and vitreous humor of albino rabbits following systemic administration of ciprofloxacin from sparse data sets by using IT2S, a population pharmacokinetic modeling program. Antimicrob. Agents. Chemother. 39(8), 1683–1687 (1995).
  • Miller MH , MaduA, SamathanamGet al. Fleroxacin pharmacokinetics in aqueous and vitreous humors determined by using complete concentration-time data from individual rabbits. Antimicrob. Agents. Chemother. 36(1), 32–38 (1992).
  • Perkins RJ , LiuW, DrusanoGet al. Pharmacokinetics of ofloxacin in serum and vitreous humor of albino and pigmented rabbits. Antimicrob. Agents. Chemother. 39(7), 1493–1498 (1995).
  • Macha S , MitraAK. Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique. Exp. Eye Res. 72(3), 289–299 (2001).
  • de Lange EC , de Boer BA, Breimer DD. Microdialysis for pharmacokinetic analysis of drug transport to the brain. Adv. Drug Deliv. Rev. 36(2–3), 211–227 (1999).
  • Gunaratna PC , KissingerPT, KissingerCB, GitzenJF. An automated blood sampler for simultaneous sampling of systemic blood and brain microdialysates for drug absorption, distribution, metabolism, and elimination studies. J. Pharmacol. Toxicol. Methods49(1), 57–64 (2004).
  • Chaurasia CS . In vivo microdialysis sampling: theory and applications. Biomed. Chromatogr. 13(5), 317–332 (1999).
  • Hansen DK , DaviesMI, LunteSM, LunteCE. Pharmacokinetic and metabolism studies using microdialysis sampling. J. Pharm. Sci. 88(1), 14–27 (1999).
  • Wang X , StenkenJA. Microdialysis sampling membrane performance during in vitro macromolecule collection. Anal. Chem. 78(17), 6026–6034 (2006).
  • Torto N , BangJ, RichardsonSet al. Optimal membrane choice for microdialysis sampling of oligosaccharides. J. Chromatogr. A806(2), 265–278 (1998).
  • Winter CD , IannottiF, PringleAK, TrikkasC, CloughGF, ChurchMK. A microdialysis method for the recovery of IL-1β, IL-6 and nerve growth factor from human brain in vivo. J. Neurosci. Methods119(1), 45–50 (2002).
  • Kendrick KM , Microdialysis measurement of in vivo neuropeptide release. J. Neurosci. Methods34(1–3), 35–46 (1990).
  • Zetterstrom T , SharpT, CollinAK, UngerstedtU. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148(3), 327–334 (1988).
  • Benveniste H , HuttemeierPC. Microdialysis – theory and application. Prog. Neurobiol. 35(3), 195–215 (1990).
  • Wages SA , ChurchWH, JusticeJBJr. Sampling considerations for on-line microbore liquid chromatography of brain dialysate. Anal. Chem. 58(8), 1649–1656 (1986).
  • Lehmann A . Effects of microdialysis-perfusion with anisoosmotic media on extracellular amino acids in the rat hippocampus and skeletal muscle. J. Neurochem. 53(2), 525–535 (1989).
  • Benveniste H . Brain microdialysis. J. Neurochem. 52(6), 1667–1679 (1989).
  • Lindefors N , BrodinE, UngerstedtU. Amphetamine facilitates the in vivo release of neurokinin A in the nucleus accumbens of the rat. Eur. J. Pharmacol. 160(3), 417–420 (1989).
  • Alexander GM , GrothusenJR, SchwartzmanJR. Flow dependent changes in the effective surface area of microdialysis probes. Life Sci. 43(7), 595–601 (1988).
  • Nicholson C , RiceME. The migration of substances in the neuronal microenvironment. Ann. NY Acad. Sci. 481, 55–71 (1986).
  • Amberg G , LindeforsN. Intracerebral microdialysis: II. Mathematical studies of diffusion kinetics. J. Pharmacol. Methods22(3), 157–183 (1989).
  • Rice ME , GerhardtGA, HierlPM, NagyG, AdamsRN. Diffusion coefficients of neurotransmitters and their metabolites in brain extracellular fluid space. Neuroscience15(3), 891–902, (1985).
  • Chastain JE . In:Ophthalmic Drug Delivery Systems. Mitra AK (Ed.). Dekker, NY, USA, 59 (2003).
  • Hart WM . Adler’s Physiology of the Eye: Clinical Application. Hart WM, Adler FH (Eds). Mosby Year Book, MO, USA,248–267 (1992).
  • Davson H . The Physiology of the Eye. Academic Press, NY, USA (1972).
  • Reddy DV , KinseyVE. Composition of the vitreous humor in relation to that of plasma and aqueous humors. Arch Ophthalmol. 63. 715–720 (1960).
  • Burstein NL , Ophthalmic drug formulations. In:Clinical Ocular Pharmacology (3rd Edition) Bartlet JD, Jaanus SD (Eds). Butterworth-Heinemann, MA, USA, 2, 21–45 (1995).
  • Kendrick KM . Use of microdialysis in neuroendocrinology. Methods Enzymol. 168, 182–205 (1989).
  • Thompson AC , JusticeJBJr, McDonaldJK. Quantitative microdialysis of neuropeptide Y. J. Neurosci. Methods60(1–2), 189–198 (1995).
  • Waga J , EhingerB. Passage of drugs through different intraocular microdialysis membranes. Graefes Arch. Clin. Exp. Ophthalmol. 233(1), 31–37 (1995).
  • Van Wylen DG , ParkTS, RubioR, BerneRM. Increases in cerebral interstitial fluid adenosine concentration during hypoxia, local potassium infusion, and ischemia. J. Cereb. Blood Flow Metab. 6(5), 522–528 (1986).
  • Delgado JM , LermaJ, Martin del Rio R, Solis JM. Dialytrode technology and local profiles of amino acids in the awake cat brain. J. Neurochem. 42(5), 1218–1228 (1984).
  • Anand BS , AtluriH, MitraAK. Validation of an ocular microdialysis technique in rabbits with permanently implanted vitreous probes: systemic and intravitreal pharmacokinetics of fluorescein. Int. J. Pharm. 281(1–2), 79–88, (2004).
  • Waga J , OhtaA, EhingerB. Intraocular microdialysis with permanently implanted probes in rabbit. Acta Ophthalmol. (Copenh.)69(5), 618–624, (1991).
  • Dey S , GundaS, MitraAK. Pharmacokinetics of erythromycin in rabbit corneas after single-dose infusion: role of P-glycoprotein as a barrier to in vivo ocular drug absorption. J. Pharmacol. Exp. Ther. 311(1), 246–255 (2004).
  • Maurice DM . Structures and fluids involved in the penetration of topically applied drugs. Int. Ophthalmol. Clin. 20(3), 7–20 (1980).
  • Doane MG , JensenAD, DohlmanCH. Penetration routes of topically applied eye medications. Am. J. Ophthalmol. 85(3), 383–386 (1978).
  • Maurice DM . Factors influencing the penetration of topically applied drugs. Int. Ophthalmol. Clin. 20(3), 21–32 (1980).
  • Levine JM , NoeckerRJ, LaneLC, HerrygersL, NixD, SnyderRW. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing. J. Cataract Refract. Surg. 30(10), 2177–2182 (2004).
  • Chien DS , SchoenwaldRD. Ocular pharmacokinetics and pharmacodynamics of phenylephrine and phenylephrine oxazolidine in rabbit eyes. Pharm. Res. 7(5), 476–483 (1990).
  • Schoenwald RD . Ophthalmic Drug Delivery Systems. Mitra AK (Ed.). Dekker, NY, USA135–180 (2003).
  • Lee VH , RobinsonJR. Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits. J. Pharm. Sci. 68(6), 673–684 (1979).
  • Makoid MC , RobinsonJR. Pharmacokinetics of topically applied pilocarpine in the albino rabbit eye. J. Pharm. Sci. 68(4), 435–443 (1979).
  • Sieg JW , RobinsonJR. Vehicle effects on ocular drug bioavailability II: evaluation of pilocarpine. J. Pharm. Sci. 66(9), 1222–1228 (1977).
  • Eller MG , SchoenwaldRD, DixsonJA, SegarraT, BarfknechtCF. Topical carbonic anhydrase inhibitors IV: relationship between excised corneal permeability and pharmacokinetic factors. J. Pharm. Sci. 74(5), 525–529 (1985).
  • Hughes PM , MitraAK. Effect of acylation on the ocular disposition of acyclovir. II: corneal permeability and anti-HSV 1 activity of 2´-esters in rabbit epithelial keratitis. J. Ocul. Pharmacol. 9(4), 299–309 (1993).
  • Tirucherai GS , DiasC, MitraAK. Corneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug design. J. Ocul. Pharmacol. Ther. 18(6), 535–548 (2002).
  • Gunda S , HariharanS, MitraAK. Corneal absorption and anterior chamber pharmacokinetics of dipeptide monoester prodrugs of ganciclovir (GCV): in vivo comparative evaluation of these prodrugs with Val-GCV and GCV in rabbits. J. Ocul. Pharmacol. Ther. 22(6), 465–476 (2006).
  • Hariharan S , GundaS, MishraGP, PalD, MitraAK. Enhanced corneal absorption of erythromycin by modulating P-glycoprotein and MRP mediated efflux with corticosteroids. Pharm. Res. 26(5), 1270–1282 (2009).
  • Lopez-Cortes LF , Pastor-RamosMT, Ruiz-ValderasRet al. Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits. Invest. Ophthalmol. Vis. Sci. 42(5), 1024–1028 (2001).
  • Fukuda M , MikitaniM, UedaTet al. Application of microdialysis on analysis of pharmacokinetics in domestic rabbits aqueous humor. Jpn. Ophthalmol. Soc. 99, 400–405 (1995).
  • Sato H , FukudaS, InatomiMet al. Pharmacokinetics of norfloxacin and lomefloxacin in domestic rabbit aqueous humor analyzed by microdialysis. Jpn. Ophthalmol. Soc. 100, 513–519 (1996).
  • Ohtori R , SatoH, FukudaSet al. Pharmacokinetics of topical β-adrenergic antagonists in rabbit aqueous humor evaluated with the microdialysis method. Exp. Eye Res. 66(4), 487–494 (1998).
  • Rittenhouse KD , PeifferRLJr, PollackGM. Evaluation of microdialysis sampling of aqueous humor for in vivo models of ocular absorption and disposition. J. Pharm. Biomed. Anal. 16(6), 951–959 (1998).
  • Rittenhouse KD , PeifferRLJr, PollackGM. Microdialysis evaluation of the ocular pharmacokinetics of propranolol in the conscious rabbit. Pharm. Res. 16(5), 736–742 (1999).
  • Rittenhouse KD , PeifferRLJr, PollackGM. Assessment of ascorbate ocular disposition in the conscious rabbit: an approach using the microdialysis technique. Curr. Eye Res. 20(5), 351–360 (2000).
  • Rittenhouse KD , PollackGM. Pharmacodynamics of β-blocker modulation of aqueous humor production. Exp. Eye Res. 70(4), 429–439 (2000).
  • Palestine AG , PolisMA, De Smet MDet al. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann. Intern. Med. 115(9), 665–673 (1991).
  • Pavan PR , OteizaEE, HughesBA, AvniA. Exogenous endophthalmitis initially treated without systemic antibiotics. Ophthalmology101(7), 1289–1296; discussion 1296–1287 (1994).
  • Daily MJ , PeymanGA, FishmanG. Intravitreal injection of methicillin for treatment of endophthalmitis. Am. J. Ophthalmol. 76(3), 343–350 (1973).
  • Stempels N , TassignonMJ, SarreS. A removable ocular microdialysis system for measuring vitreous biogenic amines. Graefes Arch. Clin. Exp. Ophthalmol. 231(11), 651–655 (1993).
  • Hughes PM , KrishnamoorthyR, MitraAK. Vitreous disposition of two acycloguanosine antivirals in the albino and pigmented rabbit models: a novel ocular microdialysis technique. J. Ocul. Pharmacol. Ther. 12(2), 209–224 (1996).
  • Chader G , SearsML. Pharmacology of the Eye. Springer-Verlag, Berlin, Germany (1984).
  • Atluri H , MitraAK. Disposition of short-chain aliphatic alcohols in rabbit vitreous by ocular microdialysis. Exp. Eye Res. 76(3), 315–320 (2003).
  • Macha S , DuvvuriS, MitraAK. Ocular disposition of novel lipophilic diester prodrugs of ganciclovir following intravitreal administration using microdialysis. Curr. Eye Res. 28(2), 77–84 (2004).
  • Macha S , MitraAK. Ocular pharmacokinetics of cephalosporins using microdialysis. J. Ocul. Pharmacol. Ther. 17(5), 485–498 (2001).
  • Duvvuri S , GandhiMD, MitraAK. Effect of P-glycoprotein on the ocular disposition of a model substrate, quinidine. Curr. Eye Res. 27(6), 345–353 (2003).
  • Dias C , NashedY, AtluriH, MitraA. Ocular penetration of acyclovir and its peptide prodrugs valacyclovir and val–valacyclovir following systemic administration in rabbits: an evaluation using ocular microdialysis and LC-MS. Curr. Eye Res. 25(4), 243–252 (2002).
  • Duvvuri S , JanoriaKG, PalD, MitraAK. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(D,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis. J. Ocul. Pharmacol. Ther. 23(3), 264–274 (2007).
  • Peng GW , ChiouWL. Analysis of drugs and other toxic substances in biological samples for pharmacokinetic studies. J. Chromatogr. 531, 3–50 (1990).
  • Fu J , FengX, YuanHet al. Study of ocular pharmacokinetics of in situ gel system for S(-)-satropane evaluated by microdialysis. J. Pharm. Biomed. Anal. 48(3), 840–843 (2008).
  • Davies MI , CooperJD, DesmondSS, LunteCE, LunteSM. Analytical considerations for microdialysis sampling. Adv. Drug Deliv. Rev. 45(2–3), 169–188 (2000).
  • Riley CM , AultJM, LunteCE. In:Progress in Pharmaceutical and Biomedical Analysis. Riley C, Lough W, Wainer I (Eds). Pergamon, NY, USA, 193–239 (1994).
  • Bergstrom SK , MarkidesKE. On-line coupling of microdialysis to packed capillary column liquid chromatography–tandem mass spectrometry demonstrated by measurement of free concentrations of ropivacaine and metabolite from spiked plasma samples. J. Chromatogr. 775(1), 79–87 (2002).
  • Niwa O , TorimitsuK, MoritaM, OsborneP, YamamotoK. Concentration of extracellular L-glutamate released from cultured nerve cells measured with a small-volume online sensor. Anal. Chem. 68(11), 1865–1870 (1996).
  • Wagstaff JD , GibbJW, HansonGR. Dopamine D2-receptors regulate neurotensin release from nucleus accumbens and striatum as measured by in vivo microdialysis. Brain Res. 721(1–2), 196–203 (1996).
  • Boismenu D , MamerO, Ste-MarieL, VachonL, MontgomeryJ. In vivo hydroxylation of the neurotoxin, 1-methyl-4-phenylpyridinium, and the effect of monoamine oxidase inhibitors: electrospray-MS analysis of intra-striatal microdialysates. J. Mass Spectrom. 31(10), 1101–1108 (1996).
  • Macha S , MitraAK. Ocular disposition of ganciclovir and its monoester prodrugs following intravitreal administration using microdialysis. Drug Metab. Dispos. 30(6), 670–675 (2002).
  • Hogan BL , LunteSM, StobaughJF, LunteCE. On-line coupling of in vivo microdialysis sampling with capillary electrophoresis. Anal. Chem. 66(5), 596–602 (1994).
  • Zhou SY , ZuoH, StobaughJF, LunteCE, LunteSM. Continuous in vivo monitoring of amino acid neurotransmitters by microdialysis sampling with on-line derivatization and capillary electrophoresis separation. Anal. Chem. 67(3), 594–599 (1995).
  • Janoria KG , BodduSH, WangZet al. Vitreal pharmacokinetics of biotinylated ganciclovir: role of sodium-dependent multivitamin transporter expressed on retina. J. Ocul. Pharmacol. Ther. 25(1), 39–49 (2009).
  • Majumdar S , KansaraV, MitraAK. Vitreal pharmacokinetics of dipeptide monoester prodrugs of ganciclovir. J. Ocul. Pharmacol. Ther. 22(4), 231–241 (2006).
  • Hicks JM . Fluorescence immunoassay. Hum. Pathol. 15(2), 112–116 (1984).
  • Waga J , EhingerB. NGF administered by microdialysis into rabbit vitreous. Acta Ophthalmol. Scand. 78(2), 154–155 (2000).
  • Li X , NieSF, KongJ, LiN, JuCY, PanWS. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int. J. Pharm. 363(1–2), 177–182 (2008).
  • Prokai L , KimHS, ZharikovaAet al. Electrospray ionization mass spectrometric and liquid chromatographic-mass spectrometric studies on the metabolism of synthetic dynorphin A peptides in brain tissue in vitro and in vivo. J. Chromatogr. A800(1), 59–68 (1998).
  • Huynh BH , FogartyBA, MartinRS, LunteSM. On-line coupling of microdialysis sampling with microchip-based capillary electrophoresis. Anal. Chem. 76(21), 6440–6447 (2004).
  • Ben-Nun J , CooperRL, CringleSJ, ConstableIJ. A new method for continuous intraocular drug delivery. Aust. N. Z. J. Ophthalmol. 17(2), 185–190 (1989).
  • Ben-Nun J , JoyceDA, CooperRL, CringleSJ, ConstableIJ. Pharmacokinetics of intravitreal injection. Assessment of a gentamicin model by ocular dialysis. Invest. Ophthalmol. Vis. Sci. 30(6), 1055–1061 (1989).
  • Louzada-Junior P , DiasJJ, SantosWF, LachatJJ, BradfordHF, Coutinho-NettoJ. Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J. Neurochem. 59(1), 358–363 (1992).
  • Tsai G , StauchBL, VornovJJ, DeshpandeJK, CoyleJT. Selective release of N-acetylaspartylglutamate from rat optic nerve terminals in vivo. Brain Res. 518(1–2), 313–316 (1990).
  • Stempels N , TassignonJM, SarreS, Nguyen-LegrosJ. Microdialysis measurement of catecholamines in rabbit vitreous after retinal laser photocoagulation. Exp. Eye Res. 59(4), 433–439 (1994).
  • Tassignon JM . Principles of the use of thermal laser photocoagulation in diabetic retinopathy. Bull. Soc. Belge. Ophtalmol. 256, 73–79 (1995).
  • Yamanaka T , SasaM, MatsunagaT. Release of glutamate from the vestibular nerve in the medial vestibular nucleus as a neurotransmitter: in vivo microdialysis study. Acta Otolaryngol. 520(Suppl., Pt 1), 92–93 (1995).
  • Adachi A , HasegawaM, EbiharaS. Measurement of circadian rhythms of ocular melatonin in the pigeon by in vivo microdialysis. Neuroreport7(1), 286–288 (1995).
  • Ebihara S , AdachiA, HasegawaM, NogiT, YoshimuraT, HirunagiK. In vivo microdialysis studies of pineal and ocular melatonin rhythms in birds. Biol. Signals6(4–6), 233–240 (1997).
  • McElligott JG , BeetonP, PolkJ. Effect of cerebellar inactivation by lidocaine microdialysis on the vestibuloocular reflex in goldfish. J. Neurophysiol. 79(3), 1286–1294 (1998).
  • Adachi A , NogiT, EbiharaS. Phase-relationship and mutual effects between circadian rhythms of ocular melatonin and dopamine in the pigeon. Brain Res. 792(2), 361–369 (1998).
  • Kurata N . [Peripheral tissue microdialysis technique in unrestrained, conscious animals]. Nippon Yakurigaku Zasshi116(3), 181–187 (2000).
  • Waga J , Nilsson-EhleI, LjungbergB, SkarinA, StahleL, EhingerB. Microdialysis for pharmacokinetic studies of ceftazidime in rabbit vitreous. J. Ocul. Pharmacol. Ther. 15(5), 455–463 (1999).
  • Waga J . Ganciclovir delivery through an intravitreal microdialysis probe in rabbit. Acta Ophthalmol. Scand. 78(3), 369–371 (2000).
  • Zhang XM , OhishiK, HiramitsuT. Microdialysis measurement of ascorbic acid in rabbit vitreous after photodynamic reaction. Exp. Eye Res. 73(3), 303–309 (2001).
  • Palhalmi J , SzikraT, KekesiKA, PappA, JuhaszG. An in vivo eyecup preparation for the rat. J. Neurosci. Methods105(2), 167–174 (2001).
  • Wei G , DingPT, ZhengJM, LuWY. Pharmacokinetics of timolol in aqueous humor sampled by microdialysis after topical administration of thermosetting gels. Biomed. Chromatogr. 20(1), 67–71 (2006).
  • Okuno T , OkuH, SugiyamaT, IkedaT. Glutamate level in optic nerve head is increased by artificial elevation of intraocular pressure in rabbits. Exp. Eye Res. 82(3), 465–470 (2006).
  • Anand BS , KatragaddaS, GundaS, MitraAK. In vivo ocular pharmacokinetics of acyclovir dipeptide ester prodrugs by microdialysis in rabbits. Mol. Pharm. 3(4), 431–440 (2006).
  • Aggarwal D , PalD, MitraAK, KaurIP. Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor. Int. J. Pharm. 338(1–2), 21–26 (2007).
  • Cao Y , ZhangC, ShenW, ChengZ, YuLL, PingQ. Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery. J. Control Release120(3), 186–194 (2007).
  • Liu Z , YangXG, LiX, PanW, LiJ. Study on the ocular pharmacokinetics of ion-activated in situ gelling ophthalmic delivery system for gatifloxacin by microdialysis. Drug Dev. Ind. Pharm. 33(12), 1327–1331 (2007).
  • Senthilkumari S , VelpandianT, BiswasNR, SaxenaR, GhoseS. Evaluation of the modulation of P-glycoprotein (P-gp) on the intraocular disposition of its substrate in rabbits. Curr. Eye Res. 33(4), 333–343 (2008).
  • Karla PK , QuinnTL, HerndonBL, ThomasP, PalD, MitraA. Expression of multidrug resistance associated protein 5 (MRP5) on cornea and its role in drug efflux. J. Ocul. Pharmacol. Ther. 25(2), 121–132 (2009).
  • Liu Z , ZhangX, LiJ, LiuR, ShuL, JinJ. Effects of labrasol on the corneal drug delivery of baicalin. Drug Deliv. 16(7), 399–404 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.